Universal building blocks for antigen presentation to uncover the flavivirus-directed antibody response

The FLAVIR project aims to develop a structural proteomics toolkit using mass spectrometry and electron microscopy to enhance understanding of neutralizing antibody responses against flaviviruses for vaccine development.

Subsidie
€ 1.687.500
2023

Projectdetails

Introduction

Flaviviruses are a tremendous burden on global public health. The genus consists of yellow fever virus, dengue virus, and zika virus amongst others. These viruses threaten more than half the global human population and are spreading into new territories. The recent zika virus pandemic stresses the need for a suitable protein engineering toolkit to enable swift development of emerging flavivirus antigens for structural studies, serology, and vaccine development.

Current Challenges

Moreover, the structural determinants of a neutralizing polyclonal antibody response are currently not well understood, in large part due to a lack of suitable methods to address the complex interactions of multiple antibodies directed against a heterogeneous, glycosylated viral antigen.

Project Overview

With FLAVIR, I will use my unique expertise in both mass spectrometry and electron microscopy to develop a comprehensive structural proteomics toolkit for in-depth profiling of the neutralizing antibody response against flaviviruses.

Methodology

Using a combination of novel mass spectrometry-based antibody sequencing techniques, glycoproteomics profiling, and electron microscopy, we will uncover how the polyclonal antibody response against flaviviruses is directed by key structural determinants of the Envelope glycoprotein that is displayed on the surface of infectious virions.

Development Strategies

We will develop new strategies to:

  1. Produce prefusion stabilized E-dimers.
  2. Ultimately reconstruct full icosahedral flavivirus-like particles from soluble components.

The outlined strategies will be tested and streamlined for broad applicability across the flaviviruses so that they can be swiftly adapted for emerging species and strains.

Characterization Techniques

We will characterize our designs with state-of-the-art mass spectrometry methods (native MS, mass photometry, HDX-MS) and electron microscopy.

Antigen Optimization

We will use these optimized antigens to uncover the role of antigen glycosylation in antibody binding, profile the serum antibody repertoire directed against the E-antigen, and map out...

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.687.500
Totale projectbegroting€ 1.687.500

Tijdlijn

Startdatum1-8-2023
Einddatum31-7-2028
Subsidiejaar2023

Partners & Locaties

Projectpartners

  • UNIVERSITEIT UTRECHTpenvoerder

Land(en)

Netherlands

Vergelijkbare projecten binnen European Research Council

ERC Starting...

Structure and Function-based Design of Vaccine Antigens and Antiviral Immunotherapies

This project aims to revolutionize vaccine antigen design by utilizing nanobody screening and deep learning to extract insights from viral glycoproteins, enhancing efficacy against high-risk viruses.

€ 1.499.525
ERC Advanced...

Molecular dissection of viral genomes for future antiviral treatments

This project aims to identify and characterize virus-encoded transmembrane proteins as novel pharmaceutical targets for antiviral drug discovery and treatment of viral infections.

€ 2.420.301
ERC Advanced...

Multivalent Supramolecular Nanosystems as Dynamic Virus Blockers

SupraVir aims to develop self-adaptive supramolecular assemblies that mimic host cell receptors to create universal virus blockers effective against diverse and rapidly mutating viruses.

€ 2.849.138
ERC Advanced...

PROposing Action to ConTrol and Impede betacoronaVirus Emergencies

Develop vaccines and monoclonal antibodies targeting subdominant epitopes of SARS-CoV-2 to ensure broad protection against current and future variants, enhancing global pandemic preparedness.

€ 2.498.750
ERC Starting...

Mosquito-virus matchmaking: Elucidating the biological basis of compatibility between viruses and mosquitoes

This project aims to utilize single-cell technology and gene editing to understand and manipulate the compatibility between viruses and mosquito vectors, enhancing disease control strategies.

€ 1.500.000

Vergelijkbare projecten uit andere regelingen

EIC Accelerator

The first broad-spectrum treatment against pandemic-prone flaviviral infections: Dengue, West-Nile and Zika

ATLAS aims to develop the first broad-spectrum antiviral for flavivirus infections, conducting Phase I and IIa trials for dengue to attract pharmaceutical partnerships for commercialization.

€ 2.499.999
Mkb-innovati...

Protini pan-Corona antivirals

Protinhi onderzoekt stoffen uit een bibliotheek voor behandelingen tegen dengue en Zika, met potentieel voor COVID-19, om patenten te ondersteunen en partners voor vervolgfinanciering te vinden.

€ 20.000